繁體中文
CONTACT US
    • Mission
    • G&E Profile
    • Chairman & CEO
    • G&E Commitment
    • Business Development
    • About SR-T100
    • SR-T100 related cosmetics Functional treatment
    • New Drug Development
    • Botanical Anti-aging Cosmetics (GlitEr series)
    • Botanical Healthcare Product(G&E series)
    • Botanical Gel(Antila series)
    • Hepato Protective Agent (Hepanamin)
    • Adult Products
    • Shareholders Services
    • Corporate Governance
    • Financial Informations
    • Operating Status
    • Announcements
    • Stock Quote
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • Foreign Agents and Distributors
    • Partnership Alliances
    • Business Relations
 
  • About SR-T100
    • Plant Cultivation
    • Bioassay Study
    • Mechanism of Action Study
    • Published Journals
    • Relevant Application
  • SR-T100 related cosmetics Functional treatment
    • SR-T100 related cosmetics Functional treatment
  • New Drug Development
    • Pipeline
    • SR-T100 Gel
    • Solarise Injection
    • Apocin Capsule
 
Home > R & D Center > About SR-T100 > Plant Cultivation
Plant Cultivation

Plants are frequently discussed as possible sources of novel drugs, and in recent years they have been investigated as potential sources of medicinal therapeutic agents including novel anti-cancerous agents. Solanum incanum was found  to have anti-cancer activity against different stages of carcinoma development.

 

G&E offers customized solutions for extractions from Solanum incanum in Taiwan. All processings of plant materials are regulated from begining of cultivation which has been developed as a line of standard operations through seedlings and harvesting.

 

The collected plant material from seeds to harvest are carefully handled to avoid contamination with airborne pathogens; this environmental protection norms laid down by the regulatory bodies. Heavy metals & pesticide residues analysis is also carefully determined to ensure the overall dimensios in compliance to FDA regulatory agency requirements, this is designed to manage risks associated with the conversion of scientific discoveries to new products & processes and eventual launch on to the market.

 

 

Apoptosis

 

 

 

   

 

Solarise Injection

 

No.92, Keji 5th Rd., Annan Dist., Tainan City 70955, Taiwan (R.O.C.)
E-MAIL:service@geherbs.com.tw   FAX : +886-6-3840918   TEL : +886-6-3840890

© 2011 G & E All rights reserved. Designed by E-SHOW